OSTEOPOROSIS TREATMENT RANKING IN POSTMENOPAUSAL WOMEN AT HIGH RISK OF FRACTURE IN BRAZIL: MCDA APPROACH

被引：0
|
作者：
Mensor, L. [1 ]
Rosim, M. P. [2 ]
Marchesan, T. [3 ]
Amaral, L. Murta [4 ]
机构：
[1] Amgen Biotecnol Brasil, Sao Paulo, SP, Brazil
[2] Amgen Biotecnol Brasil, Sao Paulo, Brazil
[3] Amgen Biotecnol Brasil, Sao Bernardo Do Campo, SP, Brazil
[4] ORIGIN Hlth, Rio De Janeiro, RJ, Brazil
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE486
引用
收藏
页码：S148 / S148
页数：1
相关论文
共 50 条
  • [1] Osteoporosis Therapy in Postmenopausal Women With High Risk of Fracture
    Cappola, Anne R.
    Shoback, Dolores M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (07): : 715 - 716
  • [2] Lifetime Risk of Fracture Among Postmenopausal Women With Osteoporosis And at High Risk of Fracture
    Brunetti, Vanessa C.
    Chien, Hsu-Chih
    McDermott, Michele
    Lin, Tzu-Chieh
    Kim, Min
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 573 - 574
  • [3] LIFETIME RISK OF FRACTURE AMONG POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AND AT HIGH RISK OF FRACTURE
    Brunetti, V. C.
    Chien, H-C
    Mcdermott, M.
    Lin, T-C
    Kim, M.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S582 - S583
  • [4] Abaloparatide: an anabolic treatment to reduce fracture risk in postmenopausal women with osteoporosis
    Miller, Paul D.
    Bilezikian, John P.
    Fitzpatrick, Lorraine A.
    Mitlak, Bruce
    McCloskey, Eugene, V
    Cosman, Felicia
    Bone, Henry G.
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (11) : 1861 - 1872
  • [5] Treatment with denosumab reduces secondary fracture risk in women with postmenopausal osteoporosis
    Palacios, S.
    Kalouche-Khalil, L.
    Rizzoli, R.
    Zapalowski, C.
    Resch, H.
    Adachi, J. D.
    Gallagher, J. C.
    Feldman, R. G.
    Kendler, D. L.
    Wang, A.
    Wagman, R. B.
    Adami, S.
    CLIMACTERIC, 2015, 18 (06) : 805 - 812
  • [6] Cost-effectiveness of romosozumab for the treatment of postmenopausal women with osteoporosis at high risk of fracture in Belgium
    Gielen, Evelien
    Aldven, Martina
    Kanis, John A.
    Borgstrom, Fredrik
    Senior, Emmanuelle
    Willems, Damon
    OSTEOPOROSIS INTERNATIONAL, 2024, 35 (07) : 1173 - 1183
  • [7] Risk of fracture and treatment to prevent osteoporosis-related fracture in postmenopausal women - A review
    Martens, MG
    JOURNAL OF REPRODUCTIVE MEDICINE, 2003, 48 (06) : 425 - 434
  • [8] Romosozumab for the treatment of postmenopausal women at high risk of fracture
    Geusens, Piet
    Appelman-Dijkstra, Natasha
    Lems, Willem
    van den Bergh, Joop
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (01) : 11 - 19
  • [9] Underuse of osteoporosis treatment in postmenopausal women at high risk for low trauma fracture: Evidence from national osteoporosis risk assessment (NORA).
    Siris, ES
    Weiss, TW
    Barlas, S
    Chen, Y
    Barrett-Connor, E
    Miller, PD
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S380 - S380
  • [10] Determinants of imminent fracture risk in postmenopausal women with osteoporosis
    R. L. Barron
    G. Oster
    A. Grauer
    D. B. Crittenden
    D. Weycker
    Osteoporosis International, 2020, 31 : 2103 - 2111
12345